Glucotrol
Product Images NDC 0049-0170

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glucotrol (NDC 0049-0170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glucotrol Xl 01)

FDA Label Image

Logo (Glucotrol Xl 02)

Logo (Glucotrol Xl 02)
This is a statement indicating that Roerig, a division of Pfizer Inc, based in New York City, is responsible for the distribution of a particular product.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
This is a distribution information indicating that Roerig, a division of Pfizer Inc located in NY, NY 10017, is responsible for distributing a certain product or item.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
This is a medication called Glucotrol XL® containing 2.75 mg of glipizide in each extended-release tablet. The medication should be stored between 68-77°F (20-25°C), but can tolerate excursions between 59°F and 86°F (15°C and 30°C). It should be dispensed in child-resistant containers and protected from moisture and humidity. The prescribing information should be consulted for dosage and use instructions. The manufacturer is Roerig Division of Pfizer Inc. and it was made in Italy. The lot and expiration date are not available.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
This is a medication label for Glucotrol XL (glipizide) extended-release tablets, containing 5.49 mg of glipizide in each tablet. The medication is dispensed in tight, child-resistant containers, and should be stored at 68-77°F (20-25°C), with permissible excursions between 59°F and 86°F (15°C and 30°C) to protect it from moisture and humidity. The prescribing information should be consulted for dosage and use guidance. The tablets are distributed by Roerig Division of Pfizer Inc, made in Italy, and the National Drug Code is 0049-0174-02.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
Store the Glucotrol XL tablets containing 10 mg dose of 10.98 mg glipizide at room temperature between 68-77°F (20-25°C) with exceptions between 59°F and 86°F (15°C and 30°C). Dispense in tight, child-proof containers and protect from moisture and humidity. Refer to the prescribing information for dosages and use. The medicine is produced in Italy and distributed by Roerig Division of Pfizer Inc. and this particular pack contains 100 tablets approved for prescription only. The NDC number is 0049-0178-07 and the lot number is PAA173350.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.